ch. 1. Obstructive airway diseases : epidemiology, etiology, and therapeutic options / Abhijit Ray -- ch. 2. Lipids : reservoir of drug targets / Abhijit Ray and Punit Kumar Srivastava -- ch. 3. Phospholipase A2 as a potential drug target for airway disorders / Yoshitaka Taketomi and Makoto Murakami -- ch. 4. 5-Lipoxygenase pathway : a validated route to drug discovery / Carlo Pergola and Oliver Werz -- ch. 5. Leukotriene receptor antagonists and FLAP inhibitors / Suman Gupta and Sanjay Malhotra -- ch. 6. EETs and Oxo-ETE in airway diseases / Jun Yang, Hua Dong, and Bruce D. Hammock -- ch. 7. The eosinophil chemoattractant 5-oxo-ETE / William S. Powell and Joshua Rokach -- ch. 8. Cyclooxygenases and prostaglandin receptors / Jitesh P. Iyer, Jitendra Anant Sattigeri, and Sunanda Ghosh Dastidar -- ch. 9. Proresolution mediators of inflammation in airway diseases : resolvins pave new directions / Bruce D. Levy and Charles N. Serhan -- ch. 10. Platelet-activating factor antagonist therapy for airway disorders / Punit Kumar Srivastava, Kent E. Pinkerton, and Rishabh Dev -- ch. 11. Lysophosophatidic acid in airway inflammation / Yutong Zhao and Viswanathan Natarajan -- ch. 12. Sphingolipids in airway inflammation / Sameer Sharma and Carole A. Oskeritzian -- ch. 13. Protein kinase C isozymes and airway inflammation / Puneet Chopra, V. Senthil, and Manish Diwan -- ch. 14. Prospects for PI3 kinase signaling inhibition in obstructive airway diseases / Kazuhiro Ito and Nicholas Mercado.